FLUDEOXYGLUCOSE F18

Post-LOE

fludeoxyglucose f 18

ANDAINTRAVENOUSINJECTABLE

Approved

Oct 2014

Lifecycle

Post-LOE

Competitive Pressure

30/100

Mechanism of Action

Radiopharmaceutical Activity

Pharmacologic Class:

Radioactive Diagnostic Agent

Company

External Resources

Full prescribing information

FDA approval history

Drug nomenclature & identifiers